These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15998692)

  • 1. Endothelial progenitor cells, neointimal hyperplasia, and hemodialysis vascular access dysfunction: novel therapies for a recalcitrant clinical problem.
    Roy-Chaudhury P
    Circulation; 2005 Jul; 112(1):3-5. PubMed ID: 15998692
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular access in hemodialysis: issues, management, and emerging concepts.
    Roy-Chaudhury P; Kelly BS; Melhem M; Zhang J; Li J; Desai P; Munda R; Heffelfinger SC
    Cardiol Clin; 2005 Aug; 23(3):249-73. PubMed ID: 16084276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.
    Roy-Chaudhury P; Sukhatme VP; Cheung AK
    J Am Soc Nephrol; 2006 Apr; 17(4):1112-27. PubMed ID: 16565259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies.
    Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
    Nat Clin Pract Nephrol; 2008 Nov; 4(11):628-38. PubMed ID: 18813234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular stenosis: biology and interventions.
    Roy-Chaudhury P; Lee TC
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):516-22. PubMed ID: 18089964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights into the pathobiology of the vascular access - do they translate into improved care?
    Diskin CJ
    Blood Purif; 2010; 29(2):216-29. PubMed ID: 20093830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular access for hemodialysis: an indepth review.
    Patel NH; Revanur VK; Khanna A; Hodges C; Jindal RM
    J Nephrol; 2001; 14(3):146-56. PubMed ID: 11439737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies.
    Roy-Chaudhury P; Kelly BS; Zhang J; Narayana A; Desai P; Melham M; Duncan H; Heffelfinger SC
    Blood Purif; 2003; 21(1):99-110. PubMed ID: 12596755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs.
    Luo Z; Akita GY; Date T; Treleaven C; Vincent KA; Woodcock D; Cheng SH; Gregory RJ; Jiang C
    Circulation; 2005 Apr; 111(13):1679-84. PubMed ID: 15781730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis.
    Lee T; Roy-Chaudhury P
    Adv Chronic Kidney Dis; 2009 Sep; 16(5):329-38. PubMed ID: 19695501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neointimal hyperplasia in early arteriovenous fistula failure.
    Roy-Chaudhury P; Arend L; Zhang J; Krishnamoorthy M; Wang Y; Banerjee R; Samaha A; Munda R
    Am J Kidney Dis; 2007 Nov; 50(5):782-90. PubMed ID: 17954291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Venopathy" at work: recasting neointimal hyperplasia in a new light.
    Yevzlin AS; Chan MR; Becker YT; Roy-Chaudhury P; Lee T; Becker BN
    Transl Res; 2010 Oct; 156(4):216-25. PubMed ID: 20875897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents.
    Cho HJ; Kim TY; Cho HJ; Park KW; Zhang SY; Kim JH; Kim SH; Hahn JY; Kang HJ; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Jul; 48(2):366-74. PubMed ID: 16843188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis vascular access dysfunction: from clinical stenosis to specific cell types.
    Roy-Chaudhury P; Munda R; Edwards J; Kelly BS
    J Nephrol; 2003; 16(2):277. PubMed ID: 12768077
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of exogenous peripheral-blood-derived endothelial progenitor cells or unfractionated bone-marrow-derived cells on neointimal formation and inflammation in cholesterol-fed, balloon-denuded, and radiated iliac arteries of inbred rabbits.
    Waksman R; Baffour R; Pakala R; Scheinowitz M; Hellinga D; Seabron R; Chan R; Kolodgie F; Virmani R
    Cardiovasc Revasc Med; 2009; 10(2):110-6. PubMed ID: 19327673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
    Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of new concepts in vascular physiology and pharmacology to improve hemodialysis access outcomes.
    Diskin CJ
    Minerva Urol Nefrol; 2010 Dec; 62(4):387-410. PubMed ID: 20944540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.
    Kim HJ; Yoo EK; Kim JY; Choi YK; Lee HJ; Kim JK; Jeoung NH; Lee KU; Park IS; Min BH; Park KG; Lee CH; Aronow BJ; Sata M; Lee IK
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1558-64. PubMed ID: 19696405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction.
    Lee T; Wadehra D
    Semin Dial; 2012; 25(1):65-73. PubMed ID: 21917012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.